Key mechanisms include: Acting on appetite centers in the brain to reduce hunger and food cravings Slowing gastric emptying, which helps individuals feel full longer Improving glucose control, which can support healthier metabolism The U.S
Join me, Vanita Aroda, Sue Pedersen, Sean Wharton and Julio Rosenstock chaired by Ildiko Lingvay on June 25 4:30-6:00 p.m
This evidence, drawn from several major clinical trials, reveals that GLP-1 RAs like Semaglutide and Tirzepatide can significantly reduce the risk of cardiovascular events, chronic kidney disease, and liver disease while improving conditions like sleep apnea and osteoarthritis
Take home message Mounjaro can cause pancreatitis, but this side effect is rare, occurring at rates similar to those of the placebo in clinical trials (0.32-0.39%)
Plant polysaccharides as novel biomaterials for microcapsule construction and therapeutics delivery